Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. - Wikidata - awgldk - TriplyDB

Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.

Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.

http://www.wikidata.org/entity/Q35059682

about

Patient considerations in the management of chronic constipation: focus on prucalopride Diagnosis and Treatment of Dyssynergic Defecation Non-pharmacological treatments for adult patients with functional constipation: a systematic review protocol Effects of Single-Dose Prucalopride on Intestinal Hypomotility in Horses: Preliminary Observations Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled Trials Persistent constipation and abdominal adverse events with newer treatments for constipation.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance Novel therapeutic agents in neurogastroenterology: advances in the past year.The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.What's New in the Toolbox for Constipation and Fecal Incontinence?A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.Prokinetics in the Management of Functional Gastrointestinal Disorders.Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults.Advancing treatment options for chronic idiopathic constipation.Velusetrag for the treatment of chronic constipation.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.Phase II drugs under clinical investigation for the treatment of chronic constipation.Current and emerging pharmacotherapeutic options for irritable bowel syndrome.Efficacy and safety of prucalopride in adults and children with chronic constipation.Management of constipation in Parkinson's disease.Emerging drugs for functional dyspepsia.New clinical trials for nonmotor manifestations of Parkinson's disease.New and Investigational Agents for Irritable Bowel Syndrome.New Options in Constipation Management.Current and Emerging Medical Therapies for Gastroparesis.Intractable Constipation in the Elderly.Prucalopride: A Review in Chronic Idiopathic Constipation.Prucalopride succinate for the treatment of constipation: an update.Constipation: Pathophysiology and Current Therapeutic Approaches.Diagnosis and management of chronic constipation in adults.Prucalopride: For functional constipation only?A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Long-term outcome of prucalopride for chronic constipation: a single-centre study.The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.An update on prucalopride in the treatment of chronic constipation.Analysis of enteroendocrine cell populations in the human colon.Pharmacotherapy for Irritable Bowel Syndrome.

P2860

Q26741304-EB56B5E5-936D-4552-9DBE-8AFC7E7D1929 Q26748507-12640776-0D8B-4088-BD16-92D111A73686 Q28658299-F2993EE1-0529-4B60-80C7-81D663B5E711 Q30364742-C5BE3C36-8BCC-4613-AADE-FBDEC85B5840 Q33467828-6C964D71-61E8-4E97-A4CD-4E2A3E1EFBB0 Q33468562-8AC785E4-3FA8-497D-BB48-58CF4C45232B Q33926234-97CA32D5-F240-4511-9250-E22966A81902 Q33934623-ECECFBBC-0358-418E-88B5-05E5DC5C20F9 Q34497909-D3630A6F-314D-49FD-955A-F3BA112C632E Q35104452-133B7B59-1750-40E9-A9AA-D77F0654EDEF Q35583251-776DDE24-062B-4C7A-886A-10F555446DF2 Q35586987-AD21A73C-E3D3-483A-BC02-117BBC3DDC97 Q35834499-7461E573-7EE3-4C55-B097-1B5D5AA69BC2 Q35844591-535B6988-3787-4873-B79D-1209BA75A4BD Q35858864-81572648-14A5-44E9-85AB-C13A8E624586 Q36042950-3B0D1220-BA0E-4EF1-AF07-7A5643A87A29 Q36082843-1C28E1BA-2A93-4BA0-BB94-C7D37F057FF8 Q37092661-60C96FAA-7DDB-4A35-902C-7B01B63151E5 Q38222819-5A5804AA-65B5-409B-A55D-4FD1A0EE4F50 Q38254747-8AB1BE10-877E-4AFA-B750-489473F6CCD5 Q38300258-0B91ECF0-273A-40C6-91C2-C9217BA0BF7C Q38300388-5C5F167E-9CCA-46E8-BC00-DAE1B790A6E1 Q38342083-D8CE1EAE-7241-4B94-A4F6-0E939C74C32F Q38587090-B6AE29CD-BBB9-480D-A8A3-C9AD418FBAD5 Q38601834-2E1DD353-EA16-412E-90AE-A990D5978EF9 Q38602701-6E7ECC0C-A824-4DCD-94A4-B0BB761F4C83 Q38617535-2D8DDB7B-416C-4FF0-BD41-04676D9EC0F8 Q38628027-F61528C6-E0F4-4A01-9869-C1CC8C3CD8FD Q38656212-7C4CE85E-1A35-4B78-B4FC-D7254F903ACA Q38662841-6B9CC49B-0D72-44AC-914C-83B90BCF0289 Q38759113-C39C7B7F-38AB-4D19-90DF-58C01D0F8F0A Q38794996-4356610E-104E-433F-A74D-9A8A8B8A3F93 Q38833279-4508C7BF-AC2A-412C-900F-0786037715DC Q39141290-1A838539-2A9C-4B36-883A-DD017F467C78 Q42695148-5831A800-5519-4AF4-B2AB-186F2EAEFCB3 Q43332981-B20A9A37-C094-429F-8A9E-BC7B9B3A09ED Q43366415-850137FB-8580-4503-9E66-8FED20846CE1 Q45044943-29D609EC-87F8-44A3-84BA-CA0BFCC0E4B3 Q46460025-DF6F2545-C6F8-4057-9959-B87C08F2D24F Q47117277-BEAB1849-436D-4BE5-9F6F-F409D3FC0831

P2860

Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.

http://www.wikidata.org/entity/Q35059682

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Systematic review with meta-an ...... ride) in chronic constipation.

@ast

Systematic review with meta-an ...... ride) in chronic constipation.

@en

type

label

Systematic review with meta-an ...... ride) in chronic constipation.

@ast

Systematic review with meta-an ...... ride) in chronic constipation.

@en

prefLabel

Systematic review with meta-an ...... ride) in chronic constipation.

@ast

Systematic review with meta-an ...... ride) in chronic constipation.

@en

P1433

Q35059682-817183D1-5837-4EFE-A72B-6CF3108926DB

P1476

Q35059682-2E9AFD49-D218-4B3A-A193-ED7C42B15D98

P2093

Q35059682-25F1C5EE-58EA-4AD2-BB0D-3F2268B3BAAB

Q35059682-867855F1-8D6B-4322-8911-7FF8ABC29F7F

Q35059682-915B96DA-8D0A-40DF-B2CB-0B210000D8B3

Q35059682-980940A3-83EE-486E-A34C-F8F23CD9B938

Q35059682-BCA0F415-69AC-4B8C-AB87-D375C3B32F92

P2860

Q35059682-047CBFD0-7B75-4414-9945-55862FAA6CC1

Q35059682-0E0D2473-7048-4867-BB94-F5C658E76C8F

Q35059682-1139F64D-E4AE-43D9-9476-37F24DAFD0D6

Q35059682-1B03146A-056D-4B24-B4A1-F299B384D27D

Q35059682-1BCE01F5-00A5-4697-BC61-65127DD67245

Q35059682-1FC3C2FB-3256-4502-BD27-02E04221220B

Q35059682-52CB7195-D326-42A4-8387-0B782E426D89

Q35059682-5A9F85DF-0CC1-4998-8E29-C9987BA171C6

Q35059682-6A2269B8-E468-4E5A-BD1E-723A30B4C502

Q35059682-6AE555AC-B54A-46CD-8CE4-5D87B9007BF4

P304

Q35059682-6FD81BEF-0D2C-4623-86B9-F87D2F296E6E

P31

Q35059682-119819b5-93ca-4ad9-b0a9-d812d95566e7

Q35059682-A7F31AB3-11F0-43ED-9548-DB6B84DFD0D2

P356

Q35059682-ACFDCD09-6A54-49FE-B55D-CED180152AFD

P407

Q35059682-1DF9107F-DB29-43BB-9ADB-E6BCB81BC0A2

P433

Q35059682-094D9789-3573-49AB-BCAE-ADDBA2C19626

P478

Q35059682-0B31089D-B977-4F33-8BD0-E243D3DBF100

P50

Q35059682-81B652B7-6029-4349-859D-25F716CD7C9B

P577

Q35059682-FBB487C6-F606-4911-98C7-E826F16947F2

P5875

Q35059682-46377027-CB8E-4A2E-8495-CAEC2C58650A

P698

Q35059682-29651555-6F17-4F31-9F81-FB5429D2E36C

P356

P1433

Alimentary Pharmacology & Therapeutics

P1476

Systematic review with meta-an ...... ride) in chronic constipation.

@en

P2093

A Shin

http://www.w3.org/2001/XMLSchema#string

C P West

http://www.w3.org/2001/XMLSchema#string

G Kolar

http://www.w3.org/2001/XMLSchema#string

M Camilleri

http://www.w3.org/2001/XMLSchema#string

P Erwin

http://www.w3.org/2001/XMLSchema#string

P2860

Why Most Discovered True Associations Are Inflated

Quantifying heterogeneity in a meta-analysis

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Psychometric validation of a constipation symptom assessment questionnaire.

Prucalopride for constipation.

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study.

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire.

Measurement of health status. Ascertaining the minimal clinically important difference.

5-HT4 receptor agonists: similar but not the same.

P304

239-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.12571

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad H. Murad

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259204754

http://www.w3.org/2001/XMLSchema#string

P698

24308797

http://www.w3.org/2001/XMLSchema#string